GLAXOSMITHKLINE PHARMACEUTICALS
Back to All Ratios
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Return on Equity (ROE) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| ROE(%) | 48.76 | 49.43 | 33.43 | 27.58 | 18.39 |
What is the latest Return on Equity (ROE) ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Return on Equity (ROE) |
|---|---|
| Mar2026 | 48.76 |
| Mar2025 | 49.43 |
| Mar2024 | 33.43 |
| Mar2023 | 27.58 |
| Mar2022 | 18.39 |
How is Return on Equity (ROE) of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Return on Equity (ROE) | % Change | |
|---|---|---|---|
| Mar2026 | 48.76 | -1.36 | |
| Mar2025 | 49.43 | 47.86 | |
| Mar2024 | 33.43 | 21.21 | |
| Mar2023 | 27.58 | 49.97 | |
| Mar2022 | 18.39 | - | |
Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Equity (ROE) ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹41,730.0 Cr | 2.2% | 11% | -25.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,704.0 Cr | -0.3% | 3.4% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,684.0 Cr | -2.5% | -1.2% | -1.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,093.0 Cr | 2.4% | 5.2% | 47.2% | Stock Analytics | |
| CIPLA | ₹117,699.0 Cr | 2.2% | 4.8% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,792.0 Cr | 4.3% | 4.1% | 4.5% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 2.2% |
11% |
-25.7% |
| SENSEX | -0.8% |
0.8% |
-7.2% |
You may also like the below Video Courses